As metabolic health continues to be a major focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in incretin mimetic medications. While all work to https://bookmarkingfeed.com/story22039195/retatrutid-vs-tirzepatid-vs-semaglutide-a-direct-look